Table 5:

Factors impacting branch vessel patency vs occluded plus stenotic—entire cohort^{^a}

	Patent Branch Vessel	Occluded/Stenotic Branch Vessel	Univariate P Value	Multivariate P Value	OR (95% CI)
Mean patient age (yr)	54.6 ± 12.6	56.0 ± 10.9	.426
Male	19/148 (12.8%)	11/69 (15.9%)	.537
Mean max aneurysm sac size	6.0 ± 4.0	5.6 ± 3.7	.096	.415	0.94 (0.82–1.09)
Mean aneurysm neck size	3.6 ± 1.7	3.4 ± 1.2	.054	.534	0.91 (0.67–1.22)
Acutely ruptured target lesion	4/148 (2.7%)	4/69 (5.8%)	.260
Mean procedural time (min)	205 ± 65	210 ± 66	.658
Mean fluoroscopy time (min)	65 ± 37	60 ± 30	.365
>1 PED deployed	14/148 (9.5%)	4/69 (5.8%)	.362
% PED classic	60/148 (40.5%)	32/69 (46.3%)	.418
Balloon angioplasty	12/148 (8.1%)	2/69 (2.9%)	.146
Mean PED diameter (mm)	4.0 ± 0.5	3.8 ± 0.5	.013	.029	0.46 (0.23–0.92)
Mean Δmax size of parent vessel and PED	0.21 ± 0.17	0.27 ± 0.25	.057	.142	3.60 (0.65–19.89)
Mean Δmin size of parent vessel and PED	0.78 ± 0.4	0.70 ± 0.42	.226
Branch vessel incorporation into aneurysm sac	42/148 (28.3%)	16/69 (27.5%)	.898
Mean periprocedural P2Y12	127 ± 68	125 ± 74	.855
Intraprocedural administration of abciximab	9/148 (6.1%)	11/69 (15.9%)	.019	.030	4.26 (1.15–15.78)
Presence of endothelial hyperplasia	31/146 (21.2%)	22/68 (32.4%)	.079	.504	1.31 (0.59–2.94)
Mean length of DSA follow-up (mo)	18.8 ± 19.4	18.0 ± 8.2	.584
A1 ACA	3/11 (27.2%)	8/11 (72.7%)	0.003	.114	3.12 (0.76–12.81)
Anterior choroidal artery	30/31 (96.8%)	1/31 (3.2%)	<.001	.003	0.04 (0.004–0.32)
PcomA	22/39 (56.4%)	17/39 (43.6%)	.081	.248	1.57 (0.73–3.40)
Ophthalmic artery	90/125 (71.2%)	36/125 (28.8%)	.23

Note:—PcomA indicates posterior communicating artery; AcomA, anterior communicationg.
↵a Percentages reflect analysis per branch vessel.